synthetick/iStock via Getty Images
GeneDx Holdings Corp. (WGS) is a diagnostics company specializing in advanced exome and genome testing services. The company's ability to interpret diagnostic test data utilizing its proprietary, deep, and expanding GeneDx
5.16K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of WGS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
SOME STOCKS MENTIONED CAN ALREADY BE PART OF THE PORTFOLIOS OF FAMILY AND ASSOCIATES and retirement accounts, and can be bought/sold in the next 72 hours. The stocks mentioned may already be part of the Prudent Biotech, Prudent Healthcare, or Prudent Small Cap model portfolios. As always, kindly do your due diligence. Small caps and biotechs carry a higher risk of losses than the broader market. Opinions can change with time and additional data, with no obligation to update.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。